MPB-2043

N/A

Report date: 2024/09/18 17:58:22
NME

Base Information

Drug NameMPB-2043
Drug Alias NameMPB-2043MPB2043
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphatic MetastasisExtranodal ExtensionSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMegapro Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMegapro Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphatic MetastasisExtranodal ExtensionSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A